Drug Discovery Informatics Market, By Solution (Software and Services), By Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, and Other functions), By Application (Drug Discovery and Drug Development), By End-user (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Report Code: PMI440720 | Publish Date: April 2023 | No. of Pages: 168

Global Drug Discovery Informatics Market Overview

Drug discovery informatics is a technique which creates a large amount of data and information on drug and diseases which is applicable for research and development.  It is generally used to ramp up the screening drug molecules. Drug discovery informatics generates correct real-time data and upsurge the speed of the drug innovation process. Increasing chronic diseases like cancer, diabetes etc. are the major factor promoting growth in the target market. The global drug discovery informatics market accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 4.9 billion by 2029 and is anticipated to register a CAGR of 8.9%.

Impact of COVID-19 on the market

Biopharmaceutical firms are at the leading position of the human response to the coronavirus pandemic. A significant number of foremost biotech organizations are in the middle of a race to examine the Sars-Cov-2 genome and formulate a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a significant amount of funds are being put into the R&D. With the several candidates in the trial, the public and private sectors are expected to work in unison for the estimative period, until a vaccine is developed for Covid-19. This report will quantify the impact of this pandemic on the drug discovery informatics market.

Global Drug Discovery Informatics Market Dynamics

Growing adoption of in-silico modelling tools

Introduction of in silico tools enables computation with diverse workflows that are in sync with the rate of modern medicinal chemistry is one of the key drift motivating the target market growth. Drug discovery is a practical procedure in pharmaceutical and biotechnology firms. It includes diverse steps and procedures that depend on in-silico tools for decreasing the complexity of a process. Identification of lead molecules needs analysis and synthesis of numerous derivatives that can be designed with the help of in silico modelling tools. The success of a drug discovery experiment relays widely on effectiveness of tools employed to measure diverse aspects of drugs. For example, in-silico tools used herein include modelling tools for determination of protein-ADMET assessment-affinity and 3D structures of ligand estimation in drug-ligand interaction and in docking for pharmacological profiling.

Advancements in web services and high-performance computing

Advancements in terms of fundamental algorithms employed by computational information processing for predictive chemistry are mainly to boost the global market in the upcoming years. This advancement helps to improve scientific innovation and laboratory informatics.

However, high installation cost and lack of trained and skilled professional are restraining the growth of this market to a certain extent. Additionally, intellectual property protection and public policy issues coupled with the presence of open-source software packages for drug discovery hampers the growth of the global market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Drug Discovery Informatics Market Segmentation

Global Drug Discovery Informatics Market

The global drug discovery informatics market is segmented based on the solution, function, application, end-user, and region.

On the basis of the solution, the global drug discovery informatics market is segmented into software and services. Based on the function, the target market is segmented into sequencing & target data analysis, docking, molecular modelling, library & database preparation, and other functions. Based on the application, the target market is classified into drug discovery and drug development. Based on the end-user, the target market is classified into pharmaceutical companies, biotechnology companies, contract research organization (CROs), and other end users.

In the region, the global drug discovery informatics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads the Drug Discovery Informatics market due to the growing incidence rates of various infectious diseases and oncology diseases. Simultaneous developments of chemical laboratories and the next-generation sequencing procedures in the region are among the major growth stimulants of the drug discovery informatics market. The Asia Pacific offers a considerable cost-saving benefit, with savings ranging from 50% to 80% of the cost as related with the developed nations, therefore leading to an expansion in the volume of clinical trials being conducted in this region. Thus, providing a substantial push to the regional market. The region is projected to experience the fastest growth over the forecast period.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

The base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Solution - Software and Services

By Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, and Other functions

By Application - Drug Discovery and Drug Development

By End-user – Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Other End Users

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029.  For the purpose of this study, has segmented the global drug discovery informatics market report based on solution, function, application, end-user, and region.

Global Drug Discovery Informatics Market, By Solution:

  • Software
  • Services

Global Drug Discovery Informatics Market, By Function:

  • Sequencing and Target Data Analysis
  • Docking
  • Molecular Modelling
  • Library & Database Preparation
  • Other functions

Global Drug Discovery Informatics Market, By Application:

  • Drug Discovery
  • Drug Development

Global Drug Discovery Informatics Market, By End-user:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Other End Users

Global Drug Discovery Informatics Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Drug Discovery Informatics Market Key Players

The key players operating in the global drug discovery informatics market include Albany Molecular Research, Inc., Certara, Collaborative Drug Discovery, Inc., Charles River Laboratories, Infosys, Boehringer Ingelheim GmBh, GVK Biosciences, DiscoverX, ChemAxon, and Jubilant Biosys. Companies are embracing the trend of collaborating with research institutes and clinical research firms to attend a competitive edge. Also, they are collaborating with the foremost pharmaceutical producers to upsurge their position in the arena. For instance, in 2017, Jubilant Life Sciences (India) collaborated with Orion Corporation to provide drug discovery services. Such collaborations help the company to attend its competitive edge as well as advertise its expertise in the drug discovery informatics market.

Global Drug Discovery Informatics Market Key Issues Addressed

Key Issues Addressed

Global Drug Discovery Informatics Market Company Profile

  • Albany Molecular Research, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategies
  • Certara
  • Collaborative Drug Discovery, Inc.
  • Charles River Laboratories
  • Infosys
  • Boehringer Ingelheim GmBh
  • GVK Biosciences
  • DiscoverX
  • ChemAxon
  • Jubilant Biosys

“*” marked represents similar segmentation in other categories in the respective section

Global Drug Discovery Informatics Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Function Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Drug Discovery Informatics Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Solution
      • Market Snippet, By Function
      • Market Snippet, By Application
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Drug Discovery Informatics Market, By Solution, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Software
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Services
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  6. Global Drug Discovery Informatics Market, By Function, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Sequencing & Target Data Analysis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Docking
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Molecular Modelling
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Library & Database Preparation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  7. Global Drug Discovery Informatics Market, By Application, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Drug Discovery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Drug Development
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  8. Global Drug Discovery Informatics Market, By End-user, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Pharmaceutical Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Contract Research Organization (CROs)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  9. Global Drug Discovery Informatics Market, By Region, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Solution, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Function, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Solution, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Function, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Solution, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Function, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Solution, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Function, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
      • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Solution, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Function, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
      • Albany Molecular Research, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Certara
      • Collaborative Drug Discovery, Inc.
      • Charles River Laboratories
      • Infosys
      • Boehringer Ingelheim GmBh
      • GVK Biosciences
      • DiscoverX
      • ChemAxon
      • Jubilant Biosys
  12. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global drug discovery informatics market is segmented based on solution, function, application, end-user, and region.

Growing adoption of in-silico modelling tools is likely to drive the growth of the global drug discovery informatics market over the forecast period.

North America leads the drug discovery informatics market due to the growing incidence rates of various infectious diseases and oncology diseases.

Companies are embracing the trend of collaborating with research institutes and clinical research firms to attend a competitive edge.